185 related articles for article (PubMed ID: 38132150)
1. Survivin-Sodium Iodide Symporter Reporter as a Non-Invasive Diagnostic Marker to Differentiate Uterine Leiomyosarcoma from Leiomyoma.
Garcia N; Ulin M; Yang Q; Ali M; Bosland MC; Zeng W; Chen L; Al-Hendy A
Cells; 2023 Dec; 12(24):. PubMed ID: 38132150
[TBL] [Abstract][Full Text] [Related]
2. Molecular Bio-Imaging Probe for Non-Invasive Differentiation Between Human Leiomyoma Versus Leiomyosarcoma.
Shalaby S; Khater M; Laknaur A; Arbab A; Al-Hendy A
Reprod Sci; 2020 Feb; 27(2):644-654. PubMed ID: 31925772
[TBL] [Abstract][Full Text] [Related]
3. Multiparametric MR evaluation of uterine leiomyosarcoma and STUMP versus leiomyoma in symptomatic women planned for high frequency focussed ultrasound: accuracy of imaging parameters and interobserver agreement for identification of malignancy.
Aminzadeh P; Alibrahim E; Dobrotwir A; Paul E; Goergen S
Br J Radiol; 2021 Mar; 94(1119):20200483. PubMed ID: 33507806
[TBL] [Abstract][Full Text] [Related]
4. Integrated histologic and molecular analysis of uterine leiomyosarcoma and 2 benign variants with nuclear atypia.
Gao T; Finkelman BS; Ban Y; Li Y; Yin P; Bulun SE; Lu X; Ha C; Wei JJ
Cancer Sci; 2021 May; 112(5):2046-2059. PubMed ID: 33338329
[TBL] [Abstract][Full Text] [Related]
5. Presurgical Identification of Uterine Smooth Muscle Malignancies through the Characteristic FDG Uptake Pattern on PET Scans.
Ho KC; Dean Fang YH; Lin G; Ueng SH; Wu TI; Lai CH; Chueh HY; Chao A; Chang TC; Yen TC
Contrast Media Mol Imaging; 2018; 2018():7890241. PubMed ID: 30018513
[TBL] [Abstract][Full Text] [Related]
6. Prognostic significance of preoperative ¹⁸F-FDG PET/CT in uterine leiomyosarcoma.
Park JY; Lee JW; Lee HJ; Lee JJ; Moon SH; Kang SY; Cheon GJ; Chung HH
J Gynecol Oncol; 2017 May; 28(3):e28. PubMed ID: 28382795
[TBL] [Abstract][Full Text] [Related]
7. Uterine Leiomyosarcoma: Can MRI Differentiate Leiomyosarcoma From Benign Leiomyoma Before Treatment?
DeMulder D; Ascher SM
AJR Am J Roentgenol; 2018 Dec; 211(6):1405-1415. PubMed ID: 30354268
[TBL] [Abstract][Full Text] [Related]
8. Can gray-scale and color Doppler sonography differentiate between uterine leiomyosarcoma and leiomyoma?
Exacoustos C; Romanini ME; Amadio A; Amoroso C; Szabolcs B; Zupi E; Arduini D
J Clin Ultrasound; 2007 Oct; 35(8):449-57. PubMed ID: 17636502
[TBL] [Abstract][Full Text] [Related]
9. How to differentiate uterine leiomyosarcoma from leiomyoma with imaging.
Sun S; Bonaffini PA; Nougaret S; Fournier L; Dohan A; Chong J; Smith J; Addley H; Reinhold C
Diagn Interv Imaging; 2019 Oct; 100(10):619-634. PubMed ID: 31427216
[TBL] [Abstract][Full Text] [Related]
10. Use of X-chromosome inactivation pattern to determine the clonal origins of uterine leiomyoma and leiomyosarcoma.
Zhang P; Zhang C; Hao J; Sung CJ; Quddus MR; Steinhoff MM; Lawrence WD
Hum Pathol; 2006 Oct; 37(10):1350-6. PubMed ID: 16949924
[TBL] [Abstract][Full Text] [Related]
11. Uterine smooth muscle tumours with hyperintense area on T
Ando T; Kato H; Furui T; Morishige KI; Goshima S; Matsuo M
Br J Radiol; 2018 Apr; 91(1084):20170767. PubMed ID: 29308922
[TBL] [Abstract][Full Text] [Related]
12. Case of uterine leiomyoma showing fludeoxyglucose uptake on F-18 fludeoxyglucose positron emission tomography/computed tomography.
Park JH; Han JY; Hyun IY; Lee BI; Moon YS
J Obstet Gynaecol Res; 2010 Dec; 36(6):1261-4. PubMed ID: 21083837
[TBL] [Abstract][Full Text] [Related]
13. Mice-lacking LMP2, immuno-proteasome subunit, as an animal model of spontaneous uterine leiomyosarcoma.
Hayashi T; Horiuchi A; Sano K; Hiraoka N; Kanai Y; Shiozawa T; Tonegawa S; Konishi I
Protein Cell; 2010 Aug; 1(8):711-7. PubMed ID: 21203912
[TBL] [Abstract][Full Text] [Related]
14. Loss of dystrophin is common in uterine leiomyosarcoma: a potential biomarker for clinical application.
Vadasz B; Felicelli C; Feng Y; Yin P; Zhang Q; Bulun S; Wei JJ
Hum Pathol; 2023 Apr; 134():85-91. PubMed ID: 36549601
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of PET/CT to exclude leiomyoma in patients with lesions suspicious for uterine sarcoma on MRI.
Kusunoki S; Terao Y; Ujihira T; Fujino K; Kaneda H; Kimura M; Ota T; Takeda S
Taiwan J Obstet Gynecol; 2017 Aug; 56(4):508-513. PubMed ID: 28805609
[TBL] [Abstract][Full Text] [Related]
16. Value of 18F-FDG PET/CT imaging in the staging, restaging, monitoring of response to therapy and surveillance of uterine leiomyosarcomas.
Bélissant O; Champion L; Thevenet H; Weinmann P; Alberini JL
Nucl Med Commun; 2018 Jul; 39(7):652-658. PubMed ID: 29683931
[TBL] [Abstract][Full Text] [Related]
17. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
18. Preoperative [
Lee JW; Park JY; Lee HJ; Lee JJ; Moon SH; Kang SY; Cheon GJ; Chung HH
Eur J Nucl Med Mol Imaging; 2018 Jul; 45(8):1309-1316. PubMed ID: 29492644
[TBL] [Abstract][Full Text] [Related]
19. MR imaging findings of unusual leiomyoma and malignant uterine myometrial tumors: what the radiologist should know.
Fujii S; Mukuda N; Ochiai R; Yunaga H; Murakami A; Gonda T; Kishimoto M; Yamaji D; Ishibashi M
Jpn J Radiol; 2021 Jun; 39(6):527-539. PubMed ID: 33517507
[TBL] [Abstract][Full Text] [Related]
20. 18F-FLT PET performs better than 18F-FDG PET in differentiating malignant uterine corpus tumors from benign leiomyoma.
Yamane T; Takaoka A; Kita M; Imai Y; Senda M
Ann Nucl Med; 2012 Jul; 26(6):478-84. PubMed ID: 22477262
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]